Skip to main content

Table 2 KEGG pathway enrichment analysis of differentially expressed genes

From:Plant transcriptome analysis reveals specific molecular interactions between alfalfa and its rhizobial symbionts below the species level

Comparisona KEGG Pathwayb P-valuec q-valuec Number of genes
G9 (LL2 vs. WLP2) Oxidative phosphorylation 3.99E-03 4
G3 (LL2 vs. QL2) Ribosome 1.17E-18 6.45E-17 52
Diterpenoid biosynthesis 4.82E-03 4
Phenylpropanoid biosynthesis 8.15E-03 11
Valine, leucine and isoleucine biosynthesis 3.15E-02 2
Q (WLP2 vs. LL1) Ribosome 1.60E-21 1.14E-19 74
Sesquiterpenoid and triterpenoid biosynthesis 2.26E-03 4
Circadian rhythm - plant 6.71E-03 5
Valine, leucine and isoleucine biosynthesis 1.05E-02 3
Amino sugar and nucleotide sugar metabolism 3.71E-02 10
L (G3L3 vs. LP3) Flavonoid biosynthesis 3.72E-12 4.09E-10 25
Plant-pathogen interaction 9.35E-11 5.14E-09 73
Alpha-Linolenic acid metabolism 7.34E-09 2.69E-07 24
Phenylpropanoid biosynthesis 3.33E-07 9.16E-06 47
Stilbenoid, diarylheptanoid and gingerol biosynthesis 1.12E-06 2.47E-05 12
Plant hormone signal transduction 1.95E-06 3.58E-05 44
Circadian rhythm - plant 1.80E-05 2.83E-04 13
Starch and sucrose metabolism 2.44E-05 3.36E-04 47
Pentose and glucuronate interconversions 4.34E-05 5.31E-04 23
ABC transporters 2.16E-04 2.38E-03 15
Linoleic acid metabolism 1.18E-03 1.18E-02 11
Carotenoid biosynthesis 2.71E-03 2.49E-02 10
Terpenoid backbone biosynthesis 6.39E-03 5.41E-02 11
Biosynthesis of unsaturated fatty acids 1.22E-02 9.01E-02 10
Glucosinolate biosynthesis 1.23E-02 9.01E-02 2
Zeatin biosynthesis 2.49E-02 5
Phosphatidylinositol signaling system 3.56 e-02 12
Cyanoamino acid metabolism 3.64E-02 14
Glycerophospholipid metabolism 3.79E-02 14
  1. aBiotype comparison on alfalfa cultivars G9 (Gannong No. 9), G3 (Gannong No. 3), Q (Qingshui) and L (Longzhong)
  2. bOnly pathways withp-value orq-value < 0.05 were presented
  3. cTheq-value is a natural pFDR (positive false discovery rate) analogue to thep-value. KEGG pathways withq-value < 0.05 were defined as significantly enriched pathways